Preferably the method is that wherein {HEAD ~ the lipid} is administered for a duration and at {TAIL ~ a dose} sufficient to maintain or elevate TGF β1 levels in the patient to therapeutic levels 
is administered at
Preferably the method is that wherein { HEAD ~ the lipid } is administered for a duration and at { TAIL ~ a dose } sufficient to maintain or elevate TGF β1 levels in the patient to therapeutic levels
OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL REL OTH OTH OTH OTH REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH